$ISIS News Health-care-related stocks keep on giving

New Post Public Reply Private Reply Replies (0) Message Board

Feb 26, 2014 at 10:58 AM

$ISIS News

Health-care-related stocks keep on giving 12:02 p.m. Feb. 12, 2014 - The Trading Deck
See the future 12:42 p.m. Feb. 3, 2014 - Cody Willard
Charting the S&P 500’s excellent 2013 adventure 11:59 a.m. Dec. 23, 2013 - Michael Ashbaugh
Market technicals tame despite debt-ceiling debate 10:43 a.m. Sept. 25, 2013 - Michael Ashbaugh
Isis reaches a new high on tests for treatment of muscular disorder 2:03 p.m. Sept. 19, 2013 - Russ Britt
Isis, Biogen working on ways to fight disease through gene altering 9:59 a.m. Sept. 9, 2013 - Russ Britt
Isis, Novartis, Halozyme all rise on positive product news 10:48 a.m. Sept. 3, 2013 - Russ Britt
Despite positive tests, investors let some air out of Isis Pharmaceuticals 10:30 a.m. July 22, 2013 - Russ Britt
5 stocks to watch 2:35 p.m. July 11, 2013 - The Trading Deck
Onyx share surge lifts several boats in biotech harbor, including ETFs 10:33 a.m. July 1, 2013 - Russ Britt
S&P’s 50-day average marks the technical test 10:39 a.m. June 27, 2013 - Michael Ashbaugh
After the close: Alexion climbs on FDA news, Biogen basks in glory 4:35 p.m. June 26, 2013 - Russ Britt
After dramatic moves, Isis and Allergan dart in different directions 5:18 p.m. June 25, 2013 - Russ Britt
Dissecting the close: Isis soars on data, while Pfizer loses on spin-off 6:26 p.m. June 24, 2013 - Russ Britt
3 ways to play the biotech boom 6:01 a.m. June 3, 2013 - Jeff Reeves
S&P 500 holds the 50-day average — barely 10:41 a.m. April 18, 2013 - Michael Ashbaugh
Biogen inks drug-development deal with Isis 2:06 p.m. Dec. 10, 2012 - MarketWatch.com
Isis: progress in early-stage study of cancer drug 7:53 a.m. Oct. 31, 2012 - MarketWatch.com
Isis Pharma rises 9% in premarket 6:22 a.m. Oct. 19, 2012 - Steve Gelsi
Investing in ‘junk DNA’ 9:28 p.m. Sept. 11, 2012 - Jen Wieczner

Growth Stocks: 7 Rallying Stocks With No Profits (Yeta????) 5:51 p.m. Feb. 24, 2014 - TheStreet.com
Isis Pharma Soars on Positive Data - Analyst Blog 1:30 p.m. Feb. 24, 2014 - Zacks.com
ISIS reiterated a Buy at Deutsche after data 11:03 a.m. Feb. 21, 2014 - Seeking Alpha
Isis therapy for spinal muscular atrophy provides encouraging results 7:41 a.m. Feb. 21, 2014 - Seeking Alpha
Isis Pharmaceuticals (ISIS): Today's Featured Drugs Laggard 5:01 p.m. Feb. 18, 2014 - TheStreet.com
Positive Opinion on Isis Pharma's ISIS-TTRRx - Analyst Blog 11:50 a.m. Feb. 18, 2014 - Zacks.com
Isis to get another $9M from Biogen 9:15 a.m. Feb. 13, 2014 - Seeking Alpha
Canadian Nod for Aegerion's Juxtapid - Analyst Blog 4:45 p.m. Feb. 11, 2014 - Zacks.com
OncoGenex Has A Potential Blockbuster Drug, But The Markets Are Pricing It Like An Orphan 9:25 a.m. Jan. 28, 2014 - Seeking Alpha
Jim Cramer's Top Stock Picks: ISIS JAZZ SYY ETH IBM 6:00 a.m. Jan. 28, 2014 - TheStreet.com
Cramer's Mad Money - We Are In Reset Mode (1/27/14) 5:06 a.m. Jan. 28, 2014 - Seeking Alpha
Jim Cramer's 'Mad Money' Recap: Market Reset 8:33 p.m. Jan. 27, 2014 - TheStreet.com
Insider Trading Alert - PLUG, UNP, OPK, ISIS And MA Traded By Insiders 10:03 a.m. Jan. 27, 2014 - TheStreet.com
Mexican Approval for Aegerion's Juxtapid - Analyst Blog 4:20 p.m. Jan. 21, 2014 - Zacks.com
Isis Pharmaceuticals, Inc. (ISIS): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 7:00 a.m. Jan. 21, 2014 - Zacks.com
Isis, Teledyne and Pandora Among Top Small-Cap Picks 6:00 a.m. Jan. 16, 2014 - TheStreet.com
Isis Pharma gets $7.5M from Alnylam 4:47 p.m. Jan. 13, 2014 - Seeking Alpha
New Lifetime High For Isis Pharmaceuticals (ISIS) 9:46 a.m. Jan. 13, 2014 - TheStreet.com
Cramer's Lightning Round - I Can't Get My Arms Around The New Kodak (1/10/14) 6:29 a.m. Jan. 12, 2014 - Seeking Alpha
'Mad Money' Lightning Round: I Don't Like Amgen 6:00 a.m. Jan. 11, 2014 - TheStreet.com

Isis Pharmaceuticals to Present at the Cowen 34th Annual Health Care Conference 7:00 a.m. Feb. 25, 2014 - PR Newswire - PRF
Critical Alerts For Cisco Systems, Michael Kors, Whole Foods Market, MetLife, and Isis Pharmaceuticals Released By InvestorsObserver 9:31 a.m. Feb. 24, 2014 - PR Newswire - PRF
Brookdale Senior Living hits 5 year high on Emeritus Acquistion; eBay acquires PhiSix 12:26 a.m. Feb. 24, 2014 - ACCESSWIRE
Isis Pharmaceuticals Reports Interim Results from ISIS-SMN Rx Phase 2 Study in Infants with Spinal Muscular Atrophy 5:00 p.m. Feb. 21, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Reports Interim Results from ISIS-SMN Rx Multiple Dose Study in Children with Spinal Muscular Atrophy 7:00 a.m. Feb. 21, 2014 - PR Newswire - PRF
Webcast Alert: Isis Pharmaceuticals' 2013 Financial Results and Highlights Conference Call 5:01 p.m. Feb. 20, 2014 - PR Newswire - PRF
Isis Pharmaceuticals to Present at the 2014 RBC Capital Markets Global Healthcare Conference 7:00 a.m. Feb. 19, 2014 - PR Newswire - PRF
Isis Announces Positive Opinion on European Orphan Drug Designation for ISIS-TTR Rx 1:32 p.m. Feb. 14, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Advances ISIS-SMN Rx in Infants and Children with Spinal Muscular Atrophy 7:00 a.m. Feb. 13, 2014 - PR Newswire - PRF
Isis Pharmaceuticals to Present at the Leerink Global Healthcare Conference 7:00 a.m. Feb. 6, 2014 - PR Newswire - PRF
Joseph Loscalzo, M.D., Ph.D., Joins Isis Pharmaceuticals' Board of Directors 2:47 p.m. Feb. 3, 2014 - PR Newswire - PRF
RXI Pharmaceuticals Could Benefit from Biotech Industry Dynamics 10:06 a.m. Jan. 24, 2014 - ACCESSWIRE
Isis Pharmaceuticals to Receive $7.5 Million from Alnylam 4:30 p.m. Jan. 13, 2014 - PR Newswire - PRF
Critical Alerts For GM, Isis Pharmaceuticals, Boston Beer, MasterCard, and Macy's Released By InvestorsObserver 9:31 a.m. Jan. 13, 2014 - PR Newswire - PRF
Upcoming Presentations and Stock Price Movements - Research Report on Bard, Regeneron, Alexion, Seattle Genetics, and Isis Pharmaceuticals 8:00 a.m. Jan. 9, 2014 - PR Newswire
NIH Data Sharing Projects Could Accelerate RNAi Field 11:16 a.m. Jan. 8, 2014 - ACCESSWIRE
Isis Pharmaceuticals to Present at the 32nd Annual J.P. Morgan Healthcare Conference 7:00 a.m. Jan. 6, 2014 - PR Newswire
Market Technicals on Thursday: Quest Diagnostics, Santarus, Isis Pharma, and Community Health Systems 8:00 a.m. Dec. 26, 2013 - PR Newswire
Stock Price Movements of Healthcare Companies- Research Report on LabCorp, Isis Pharmaceuticals, Mindray, Clovis Oncology and Sangamo Biosciences 8:00 a.m. Dec. 23, 2013 - PR Newswire
Surgical Scar Market Is Ripe for Innovation 11:15 a.m. Dec. 18, 2013 - ACCESSWIRE

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

OCI N.V. Secures a Win in Court; EGM Proceeds as Planned

OCI Dodges a Bullet in Amsterdam Court Stepping into the courtroom drama, OCI N.V. just took home a win as the Amsterdam Court of Appeal's Enterprise Chamber gave them a clean bill of health, kicking out the inquiry request from VEB and a bunch of other shareholders. The judges weren't convinced there was anything fishy going on, so they tossed the inquiry petition and...

Vitamin Angels Drives Global Nutrition Advancements

Navigating the Waters of Global Nutrition Bet you never thought a vitamin program could spearhead the front lines of healthcare, huh? Vitamin Angels are grinding away under the radar, shifting the landscape for maternal and child nutrition. At the heart of it all is their vision to make UNIMMAP multiple micronutrient supplementation (MMS) a staple in the global playbook....

Wally Disrupts Dental Industry with $25M Funding

A New Breath of Fresh Air for Dental Care Dental visits—a tedious, costly affair we've all dreaded. So, when Wally rolls out an overhaul in this stale landscape, it's worth taking notice. With $25 million in their pockets from Series A funding led by Maveron, Wally's swaggering in with a plan to flip the script on dental care across the nation. Redefining the Dental...

U. of Phoenix and LACCD Launch 3+1 Degree Pathway

Opening the Floodgates for Ambitious Community College Students When it comes to climbing the educational ladder, not everyone starts at the same rung. That's a fact we've all come to terms with in one way or another. Enter the University of Phoenix and the Los Angeles Community College District with a solution to expand educational access. The 3+1 Program: A Cost-Saving...

Duke Energy's Cost-Protection Plan Shields Ratepayers

Shielding Customers From Data Center Costs Let's get right into the thick of it: Duke Energy's latest move is a strategic one, shrouded in industry terms but with a real impact on regular folks' wallets. The company's agreement with heavyweights like Amazon, Google, and Meta aims to protect existing customers in North Carolina from getting hit with the costs of powering...

C3EL Expands Federal Footprint with Strategic Contracts

Pushing Boundaries in Federal Contracts What a ride C3EL's had in Government Fiscal Year 2026! Let me tell you, they’ve bagged a bunch of contracts that’d make any company’s mouth water. Kicking things off, they snagged a prime cybersecurity contract from the U.S. Air Force. Considering our current cybersecurity landscape, that's like striking gold. But they...

EMCO's New Automated Facility Could Shake Industry

A Novel Leap in Production Capacity EMCO Industries just put a solid foot on the accelerator with their brand-new, shiny, fully automated plant over in Claremore, Oklahoma. If you're glancing at heavy-duty trailer springs, you can't ignore the fact that this is a multimillion-dollar investment. Heck, this monstrous 30,000-square-foot facility more than doubles what EMCO...

Ornellaia's 2026 Harvest: Adapting to Nature's Whims

A Year Marked by Weather's Unpredictable Dance Nobody said making wine was a walk in the park, and the folks at Ornellaia know better than most how to roll with whatever nature throws their way. The 2026 harvest story is as much about unlocking the secrets of the soil as it is about navigating the quirks of the weather. Situated in Bolgheri, Italy, this year's vintage...

Gong, Agentforce, Avoma Crowned 2026 CI Champions

Diving Deep into Conversation Intelligence There's a lot to unpack when three software titans hog the spotlight, and that's exactly what's happening in the world of conversation intelligence this year. It's like we've hit the jackpot with Gong, Agentforce Sales, and Avoma carving out their turf as the 2026 Champions, according to the venerable Info-Tech Research Group....

Decoding CarBravo-Certified vs Traditional Used Cars

What’s Behind Door Number One: CarBravo Certification When you walk onto a car lot these days, it's a mixed bag: shiny badges boasting certifications or basic used car signage. For anyone who's spent time around cars, two types stick out—there’s your CarBravo-certified vehicles and your good ol' used cars. Now, Marissa McCoy and Jill Maniaci from Heidebreicht...